Reta glucagon-like peptide-1 (GLP-1) receptor agonists provide a groundbreaking strategy to diabetes management. These innovative drugs operate by mimicking the inherent actions of GLP-1, a hormone released by the gut https://socialwebnotes.com/story5914655/glp-1-receptor-agonists-as-a-novel-therapy-for-diabetes